小鼠艾氏腹水癌细胞内3'''',5''''-环腺苷酸(cAMP)的免疫荧光细胞化学定位和外源性cAMP对癌细胞内cAMP的影响

本工作用显示cAMP的免疫荧光细胞化学方法观察了小鼠艾氏腹水癌细胞内cAMP的分布,并发现经外源性cAMP及氨茶碱处理后,有使小鼠艾氏腹水癌细胞内cAMP荧光增强的效应。cAMP主要分布在胞质内。实验组动物从接种癌细胞的次日起,每日从腹腔注射2毫克的cAMP和1毫克的氨茶碱,发现在接种后第9天,大多数癌细胞胞质内的cAMP荧光增强,以核周区胞质内的荧光最显著。进一步证实了我室以前用生化测定癌细胞内cAMP含量的结果。本文并对显示cAMP的免疫荧光细胞化学方法进行了讨论,用cAMP荧光染色反应的特异性鉴定证明了方法的可靠性。     

cGMP、cAMP及两种cAMP衍生物对大鼠肝细胞核体外转录系统的影响

 本文介绍了以α-鹅膏蕈碱和低浓度KCl为手段建立了RNA聚合酶Ⅰ、RNA聚合酶Ⅱ活性的细胞核转录系统进而研究了cGMP、cAMP、cAMP丁酯及cAMP硫代环磷酰二乙胺对大鼠肝细胞核中RNA聚合酶Ⅰ与Ⅱ活性的影响。结果显示cGMP可以提高RNA聚合酶Ⅰ的活性;cAMP主要提高RNA聚合酶Ⅱ的活极,而cAMP分子结构变化产生的丁酯及硫代环磷酰二乙胺衍生物可增强cAMP的这种作用,为深入研究cAMP的构效关系提供了实验依据。     

精氨酸加压素、神经降压素和强啡肽对神经母细胞瘤细胞cAMP和cGMP的影响

本文报道小鼠神经母细胞瘤细胞在无血清培养条件下,用cAMP和cGMP放射免疫测定方法,观察AVP、NT和DYN对小鼠神经母细胞瘤细胞内cAMP和cGMP水平及cAMP/cGMP比值的影响。结果发现:AVP使cAMP水平和cAMP/cGMP比值显著升高(P<0.01);DYN使cGMP水平升高(P<0.01),但cAMP/cGMP比值下降;NT使cAMP水平和cAMP/cGMP比值下降,同时又使cGMP水平升高。结果提示:这三种神经肽可以分别对神经母细胞瘤细胞内cAMP、cGMP水平和cAMP/cGMP比值产生影响。     

妊娠期妇女尿中环3′,5′-一磷酸腺苷含量的变化

自从1962年Sutherland发现并提出环3′,5′——磷酸腺苷(以下简称cAMP)作为“第二信使”参与多种激素的作用以来,有关cAMP在激素作用中及生理上的重要意义的研究报道日益增多,特别是由于建立了较为简单而敏感的cAMP测定方法,更给这方面的研究提供了有利条件。近年来,除了发现cAMP广泛存在于哺乳动物的细胞和体液内,同时还发现它在尿中的排泄量远较细胞内和血浆内的含量为高。曾有些学者通过尿cAMP的测定发现cAMP含量与某些疾病的关系,如甲状旁腺机能亢进、高血压症等尿cAMP水平升高,甲状旁腺机能减退患者尿cAMP水平降低。Taylor(1970)首次报道了妊娠期妇女尿     

环腺苷酸(cAMP)对粗柄羊肚菌菌丝生长和菌核发生的影响

通过外源添加环腺苷酸(cAMP)、腺苷酸环化酶激活剂氟化钠(NaF)和cAMP降解产物腺苷酸(AMP),研究了cAMP对粗柄羊肚菌菌丝生长和菌核发生的影响,并测定了不同菌核发育阶段培养物的胞内cAMP浓度。结果表明:在测试浓度范围内,cAMP对粗柄羊肚菌菌丝生长影响不显著,但显著抑制该真菌菌核的发生。菌核数量与外源添加的cAMP和NaF具有明显的剂量负相关性。然而,AMP显著促进粗柄羊肚菌菌丝生长,却没有明显影响其菌核发生。培养物胞内cAMP浓度随着培养时间的延长而增加,与外源添加cAMP抑制菌核发生的结果一致。本研究为羊肚菌菌核发生的分子机制研究提供理论支持。     

环化腺苷酸对细菌生长的影响

用大肠杆菌(Escherichia coli AS 1.797)、北京棒状杆菌(Corynebacterium pekinense AS1.299)和巨大芽孢杆菌(Bacills megatertum AS 1.217)研究了细胞内环化腺苷酸(cAMP)浓度和外源cAMP对细胞生长的影响。结果表明,大肠杆菌在不同碳源中生长时,细胞的生长量随细胞内cAMF’浓度升高而降低。在以葡萄糖作碳源时,细胞内cAMP浓度低,外源cAMP。对生长有抑制作用,而cAMP的类似物5'-AMP则无抑制作用。在以乳糖、麦芽糖和甘油分别作碳源时,细胞内cAMP浓度高,外源cAMP对生长无影响。北京捧状杆菌以葡萄糖作碳源时,细胞生长也受外源cAMP的抑制,但cAMP的抑制作用不是专一的,它的作用可用类似物5’-AMP来代替。自身不合cAMP的巨大芽孢杆菌在不同碳原(包括葡萄糖)中生长时,生长不受外源cAMP抑制,也不受5’-Amt’的影响。因此认为,cAMP不是细菌生长的必需物,而是生长调节物,但这种调节物对巨大芽孢杆菌无效。     

注射依赖cAMP的蛋白激酶催化亚基加速胚胎内细胞间连接通讯的发育(英文)

本研究以爪蟾胚胎内胚层细胞间连接通讯发育的时程为指标,观察了cAMP和依赖cAMP的蛋白激酶催化亚基对这一发育的影响。将依赖cAMP的蛋白激酶催化亚基注射入爪蟾胚胎四细胞期的每一个细胞可使该胚胎内胚层细胞间连接通讯的发育明显加快,提示在正常状态下这一发育的进程是受细胞内依赖cAMP的磷酸化水平的制约。但用双丁酰cAMP和磷酸二酯酶抑制剂对胚胎进行培育,或将cAMP和磷酸二酯酶抑制剂注射入胚胎细胞,对这一发育并无影响,可能是由于这些胚胎细胞内依赖cAMP的蛋白激酶的实际有效含量较低而cAMP含量较高所致。注射这种蛋白激酶催化亚基所诱导的胚胎细胞间连接通讯在注射后约8.5小时出现。这一时间比前人在哺乳动物细胞培养中用cAMP或必需的信使RNA诱导出细胞间连接通讯所需要的时间(2—4小时)长得多,提示在胚胎中依赖cAMP的磷酸化对细胞间连接通讯发育的作用是从RNA转录的水平上开始的。     

cAMP的生物学作用:生物间的相似性和差异

在真核生物和原核生物中,cAMP的作用方式是完全不同的,虽然,在这两类生物中与cAMP结合的蛋白质可能有共同的进化起源。尽管在很不相同的生物中保存了cAMP的某些调节方式,但仍有这样一些情况,即cAMP的作用从一种细胞类型到另一种细胞类型有着广泛的变化。特别是,cAMP不能当作一种通用的“饥饿”信号。     

四膜虫S1营养生长和有性过程中cAMP的含量变化

用放射免疫法测定了四膜虫在群体生长各阶段和在有性过程中cAMP的含量变化。在群体生长的延迟期(Lag phase)之末,即将进入对数期时,cAMP含量出现一个峰值。随着对数期的进展,cAMP含量陆续下降,在对数期之末,cAMP含量降至最低值。群体进入静止期后,细胞内cAMP含量略有回升。 在饥饿诱导接台的过程中,细胞内cAMP含量在开始饥饿的很短时间内即迅速降至一个最低点,并且在整个接合过程中一直保持较低的水平。接合抑制剂伴刀豆球蛋白A(CoaA)和精胺(spermine)等在抑制接合的同时,也阻止饥饿细胞cAMP含量的迅速下降,使之不能达到在正制情况下接合出现时所达到的低水平。 在饥俄细胞的培养液中检出了较高量的cAMP。这可能有助于说明何以饥饿细胞的cAMP含量能够在很短时间内迅速下降。至于排出的cAMP对四膜虫的接合有无促进或其他作用,有特继续研究。     

L615白血病小鼠肝、脾中cAMP依赖的蛋白激酶活力变化

cAMP不仅参与细胞的多种代谢调节过程,而且还和细胞的增殖、分化有关。cAMP要发挥其生理效应,需通过cAMP依赖的蛋白激酶才能实现。有报道认为肿瘤细胞的恶性行为可能和其细胞内cAMP水平下降有关。另有人认为肿瘤细胞内cAMP下降不是主要原     

Cyclic AMP-induced conformational change of cyclic AMP receptor protein (CRP): intragenic suppressors of cyclic AMP-independent CRP mutations.

We isolated and characterized crp mutations in Escherichia coli that allow cyclic AMP (cAMP) receptor protein to function without cAMP. These mutants defined a region involved in the cAMP-induced allosteric change of cAMP receptor protein that is necessary for activation of the protein. Currently, we have isolated intragenic suppressors of the crp mutations. These crp (Sup) mutants require cAMP for activity. The crp (Sup) mutations map in regions which define new sites of changes involved in cAMP receptor protein activation. From these results, we suggest that to activate cAMP receptor protein cAMP brings about (i) a hinge reorientation to eject the DNA-binding F alpha-helices, (ii) proper alignment between the two subunits, and (iii) an adjustment between the position of the two domains. Cyclic GMP fails to effect the last step.     

Cyclic AMP inhibits JNK activation by CREB-mediated induction of c-FLIP(L) and MKP-1, thereby antagonizing UV-induced apoptosis

The cyclic AMP (cAMP) signaling pathway has been reported to either promote or suppress apoptosis, in a cell context-dependent manner. Our previous study has shown that cAMP, by protein kinase A (PKA)-cAMP response element-binding protein (CREB)-dynein light chain (DLC) pathway, negatively regulates mitogen-activated protein kinase p38 activation, thereby contributing to tumor necrosis factor (TNF)-alpha-induced apoptosis in certain types of cells. However, it remains largely unknown how cAMP suppresses apoptosis. Here we report that cAMP antagonized UV-induced apoptosis in Rat-1 and NIH 3T3 cells. Despite that cAMP significantly suppressed UV-induced p38 activation, inhibition of p38 activity showed no significant effect on UV-induced cell death in both cell lines. Further studies revealed that cAMP antagonized UV-induced apoptosis by inhibition of c-Jun N-terminal protein kinase (JNK) activation. The induction of the long form of cellular FLICE-inhibitory protein (c-FLIP(L)) and mitogen-activated protein kinase phosphatase-1 (MKP-1), but not DLC and p21(WAF1) by CREB was required for cAMP-mediated inhibition of JNK activation. The suppression by cAMP of UV-induced apoptosis was reversed by c-FLIP(L) small-interfering RNA (siRNA) or MKP-1 siRNA, which released the inhibition of JNK activation by cAMP. Thus, our results provide a molecular mechanism by which cAMP suppresses JNK activation and antagonizes apoptosis.     

A method for stimulation of cyclic AMP levels in vivo by intracerebral injection in the rat olfactory tubercle

A method is described for stimulation of cAMP levels in brain by direct injection of dopamine (DA) and other neuroactive substances. Intracerebral microinjection was preceded by intraperitoneal injection of 3-isobutyl-1-methylxanthine (IBMX) to inhibit cyclic nucleotide phosphodiesterase. In vivo adenylate cyclase and phosphodiesterase activities were terminated by focused microwave radiation and the injected tissue assayed for protein and cAMP content. Increases in cAMP levels in response to injections of DA were both time- and dose-dependent. Animals receiving only vehicle or sham injections into the olfactory tubercle had basal cAMP levels of 5 pmol/mg protein. Up to five-fold increases above basal (25 pmol cAMP/mg protein) were observed for DA. With the injection of other neuroactive substances, values ranging from 160 pmol cAMP/mg protein for norepinephrine (NE), to 15 pmol cAMP/mg protein for gamma-amino butyric acid (GABA) were observed. The present study demonstrates that neuroactive substances can stimulate cAMP production in vivo when injected directly into brain tissue.     

Adenosine cyclic 3',5'-monophosphate uptake and regulation of membrane protein kinase in intact human erythrocytes

The uptake of adenosine cyclic 3',5'-monophosphate (cAMP) and stimulation of membrane-associated protein kinase in mature human erythrocytes were investigated. cAMP transport across the membrane was temperature dependent, and cAMP binding to the isolated membrane had less temperature dependence. More than 99% of the [3H]-cAMP taken up by erythrocytes was nonmembrane bound. Maximal stimulation of membrane protein kinase and maximal occupancy of membrane cAMP binding sites by extracellular cAMP cccurred at 30 degrees C within 30 min after initiation of the incubation of erythrocytes with cAMP. The concentration of extracellular cAMP that gave half-maximal stimulation of membrane protein kinase was 5.4 X 10-4 M, a value consistent with the concentrations of cAMP (5.2 X 10-4 M) found to occupy half-maximally the membrane cAMP binding sites in erythrocytes. Extracellular cAMP and to a lesser extent guanosine cyclic 3',5'-monophosphate and inosine cyclic 3',5'-monophosphate stimulated membrane protein kinase in erythrocytes. The cAMP uptake by human erythrocytes as well as cAMP binding to membranes in the erythrocyte was blocked by an inhibitor [4,4'-bis(isothiocyano)stilbene-2,2-disulfonate] of the anion channel. These studies indicate that cAMP can be transported across membranes into human erythrocytes and can bind to membranes to activate membrane protein kinase. It appears that there is a shared transport channel for cAMP and anion transport.     

Protein-bound cAMP, total cAMP, and protein kinase activation in isolated bovine thyrocytes.

Thyrocytes isolated from bovine thyroid tissue were subjected to thyrotropin treatment and analyzed for total cAMP, protein bound cAMP and protein kinase activation. The concentration of thyrotropin (～4 mU/ml) required for half-maximal elevation of total cAMP was 20 times greater than the concentration required for half-maximal elevation of protein kinase activity and bound cAMP levels (～0.2 mU thyrotropin/ml). In thyrocytes, bound cAMP and protein kinase activation showed a linear, one to one relationship indicating that bound cAMP obtained with the charcoal procedure is largely or completely identical with R·cAMP.     

A cAMP-binding phosphoprotein in Drosophila heads is similar to the regulatory subunit of the mammalian type II cAMP-dependent protein kinase

Cyclic AMP (cAMP)-dependent regulation of in vitro phosphorylation of several proteins including a cAMP-binding protein was studied with crude membrane and cytosol fractions from Drosophila heads. Phosphorylation of at least seven distinct proteins was enhanced in the presence of cAMP. Interestingly, however, the phosphorylation of a 56 kDa protein was apparently reduced by cAMP in the membrane but not in the cytosol fraction. The following data strongly indicate that the 56 kDa phosphoprotein in both membrane and cytosol fractions is a cAMP-binding protein, very similar to the regulatory subunit (RII) of a mammalian cAMP-dependent protein kinase, and that its binding to cAMP makes this protein very susceptible to the action of phosphatases: (i) cAMP highly stimulated the dephosphorylation of the 56 kDa phosphoprotein by the endogenous phosphatase in the membrane fraction. (ii) The dephosphorylation of a similar 56 kDa phosphoprotein in the cytosol fraction by an exogenous, cAMP-independent, alkaline phosphatase was also highly stimulated by cAMP. (iii) The 56 kDa phosphoprotein was covalently bound to cAMP by u.v. irradiation. (iv) The alkaline-phosphatase treatment reversibly converted this phosphoprotein to a 53 kDa non-phosphorylated protein. (v) The 53 kDa protein was selectively bound to cAMP-agarose and subsequently eluted by cAMP and high salt. (vi) This protein served as a substrate for the catalytic subunit of a mammalian cAMP-dependent protein kinase.     

Steady-state and time-resolved fluorescence studies of conformational changes induced by cyclic AMP and DNA binding to cyclic AMP receptor protein from Escherichia coli.

cAMP receptor protein (CRP), allosterically activated by cAMP, regulates the expression of several genes in Escherichia coli. As binding of cAMP leads to undefined conformational changes in CRP, we performed a steady-state and time-resolved fluorescence study to show how the binding of the ligand influences the structure and dynamics of the protein. We used CRP mutants containing a single tryptophan residue at position 85 or 13, and fluorescently labeled with 1,5-I-AEDANS attached to Cys178. Binding of cAMP in the CRP-(cAMP)2 complex leads to changes in the Trp13 microenvironment, whereas its binding in the CRP-(cAMP)4 complex alters the surroundings of Trp85. Time-resolved anisotropy measurements indicated that cAMP binding in the CRP-(cAMP)2 complex led to a substantial increase in the rotational mobility of the Trp13 residue. Measurement of fluorescence energy transfer (FRET) between labeled Cys178 and Trp85 showed that the binding of cAMP in the CRP-(cAMP)2 complex caused a substantial increase in FRET efficiency. This indicates a decrease in the distance between the two domains of the protein from 26.6 A in apo-CRP to 18.7 A in the CRP-(cAMP)2 complex. The binding of cAMP in the CRP-(cAMP)4 complex resulted in only a very small increase in FRET efficiency. The average distance between the two domains in CRP-DNA complexes, possessing lac, gal or ICAP sequences, shows an increase, as evidenced by the increase in the average distance between Cys178 and Trp85 to approximately 20 A. The spectral changes observed provide new structural information about the cAMP-induced allosteric activation of the protein.     

Escherichia coli cAMP receptor protein: evidence for three protein conformational states with different promoter binding affinities

Cyclic AMP receptor protein (CRP) from Escherichia coli is assumed to exist in two states, namely, those represented by the free protein and that of the ligand-protein complex. To establish a quantitative structure-function relation between cAMP binding and the cAMP-induced conformational changes in the receptor, protein conformational change was quantitated as a function of cAMP concentration up to 10 mM. The protein conformation was monitored by four different methods at pH 7.8 and 23 degrees C, namely, rate of proteolytic digestion by subtilisin, rate of chemical modification of Cys-178, tryptophan fluorescence, and fluorescence of the extrinsic fluorescence probe 8-anilino-1-naphthalenesulfonic acid (ANS). Each of these techniques reveals a biphasic dependence of protein conformation on cAMP concentration. At low cAMP concentrations ranging from 0 to 200 microM, the rates of proteolytic digestion and that of Cys-178 modification increase, whereas the fluorescence intensity of the ANS-protein complex is quenched, and there is no change in the fluorescence intensity of the tryptophan residues in the protein. At higher cAMP concentrations, the rates of proteolytic and chemical modification of the protein decrease, while the fluorescence intensity of the ANS-protein complex is further quenched but there is an increase in the intensity of tryptophan fluorescence. These results show unequivocally that there are at least three conformational states of the protein. The association constants for the formation of CRP-cAMP and CRP-(cAMP)2 complexes derived from conformational studies are in good agreement with those determined by equilibrium dialysis, nonequilibrium dialysis, and ultrafiltration. Therefore, the simplest explanation would be that the protein exhibits three conformational states, free CRP and two cAMP-dependent states, which correspond to the CRP-cAMP and CRP-(cAMP)2 complexes. The binding properties of CRP-cAMP and CRP-(cAMP)2 to the lac promoter were studied by using the gel retardation technique. At a high concentration of cAMP which favors the formation of the CRP-(cAMP)2 complex, binding of the protein to DNA is decreased. This, together with conformational data, strongly suggests that only the CRP-cAMP complex is active in specific DNA binding whereas CRP and CRP-(cAMP)2 are not.     

cAMP binding protein assay for widespread use in cell signaling studies

cAMP plays a critical role in intracellular signaling pathways that regulate proliferation or differentiation. The cAMP binding protein assay, using a naturally derived cAMP binding protein, is one of the most widely used methods for cAMP determination. The major steps of this binding assay include purification of the binding protein, cAMP extraction from samples, and quantification of the cAMP Most purification methods of the cAMP binding protein were published before 1975, and many of the materials and methods are outdated. Here we describe an updated method of purification of cAMP binding protein from bovine skeletal muscle with the advantages of simplicity, low cost, and high yield The isolation procedures can be completed in two days using commercially available materials and equipment. The cAMP binding properties of the isolated protein can be utilizedfor more than two years. Binding protein isolatedfrom 1 kg bovine muscle is sufficientfor at least 3 x10(4) assay tubes. Furthemore, we describe the techniques of cAMP extraction and quantification that have been used successfully in studying parathyroid hormone signaling as an example of a G protein-linked seven transmembrane domain receptor that signals through the protein kinase A pathway.     

Multiple protein kinase activities in the dimorphic fungus Mucor rouxii. Comparison with a cyclic adenosine 3',5'-monophosphate binding protein.

Protein kinase and cyclic adenosine 3′,5′-monophosphate (cAMP) binding activities have been detected in cell extracts of the dimorphic fungus Mucor rouxii. The subcellular distribution of both activities indicates that most of the binding protein is in the high-speed supernatant (S₁₀₀), while about 70% of the total protein kinase activity remains in particulate fractions. S₁₀₀ preparations have been analyzed by diethylaminoethyl cellulose column chromatography. Binding activity can be resolved in two peaks (A and B) and protein kinase in three peaks (I, II, and III). Peaks I and II are casein dependent and insensitive to cAMP. Peak III utilizes histone as substrate and is activated (two- to fourfold) by cAMP. Theophylline strongly inhibits cAMP binding activity and mimics the effect of cAMP on cAMP-dependent protein kinase. The possible relationship between cAMP binding activity and cAMP-dependent protein kinase is suggested.